In patients undergoing percutaneous cardiovascular procedures, RenalGuard was associated with a reduced risk of CA-AKI and acute pulmonary edema compared with standard periprocedural hydration strategies.Īcute kidney injury Angiografía coronaria Angioplastia Contrast media Coronary angiography Lesión renal aguda Medios de contraste yodado Nefropatía inducida por contraste Percutaneous coronary intervention.Ĭopyright © 2023. These results were consistent in multiple sensitivity analyses. The Bayesian analysis also showed that RenalGuard had a high probability of ranking first for all the secondary outcomes. No significant differences were observed for the other secondary endpoints. ![]() ![]() RenalGuard was associated with a significant relative reduction in CA-AKI (median RR, 0.54 95%CrI, 0.31-0.86) and acute pulmonary edema (median RR, 0.35 95%CrI, 0.12-0.87). Presentamos diferentes entidades clnicas que se han. A Bayesian random-effect risk ratio (RR) with corresponding 95% credibility interval (95%CrI) was calculated for each outcome. Sus principales desventajas derivan del uso de radiacin ionizante y medio de contraste yodado. Secondary outcomes were all-cause death, cardiogenic shock, acute pulmonary edema, and renal failure requiring renal replacement therapy. We searched Medline, Cochrane Library and Web of Science for randomized trials of RenalGuard vs standard periprocedural hydration strategies. We used a Bayesian framework to perform a meta-analysis of RenalGuard as a CA-AKI preventive strategy. El uso de medios de contraste intravenosos en estudios radiolgicos es de gran importancia es el. ![]() The evidence on RenalGuard in patients undergoing percutaneous cardiovascular procedures is sparse. medios de contraste yodados, nefropata, tomografa. RenalGuard, which provides real-time matching of intravenous hydration with furosemide-induced diuresis, is an alternative to standard periprocedural hydration strategies. En la mayora de los casos es temporal y reversible, aunque puede aumentar la morbimortalidad intrahospitalaria en pacientes con factores de riesgo. O extravasamento de contraste iodado é considerado evento adverso local à administração intravenosa da substância radiopaca. Contrast-associated acute kidney injury (CA-AKI) is a potential complication of procedures requiring administration of iodinated contrast medium. Los medios de contraste yodados son ampliamente utilizados en las consultas de Radiologa con una tasa muy baja de efectos adversos, siendo la nefropata inducida por contraste la ms grave. contraste iodado apresentam freqüência que varia entre 2,2 e 12,7 com uso do meio iônico e entre 0,2 e 3,1 com o contraste não iônico(1-2,7).
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |